Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Ann Hematol. 2017 Nov 16;97(2):239–246. doi: 10.1007/s00277-017-3182-8

Fig. 2. Performance of the point-of-care sickle cell disease assay.

Fig. 2

After mixing the sample with the buffer, and placing on the application pad, the presence of HbA, HbS, and HbC are indicated by a darkened horizontal band. Results are easily interpreted within 5 minutes